CSL (ASX:CSL) - CEO & Managing Director, Paul Perreault
CEO & Managing Director, Paul Perreault
Source: CSL Behring
Market Herald logo

Find out more about this capital raise

Be the first with the news that moves the market
  • CSL (CSL) is gearing up to raise capital for the first time in over five years to help it fund an acquisition, as takeover talks with Vifor Pharma continue
  • The healthcare giant confirmed recently it was holding talks with Vifor about potentially buying the Swiss-based pharmaceutical company
  • CSL entered a trading halt on Tuesday and is due to remain halted until Thursday, unless an announcement can be made sooner
  • The ASX-10 lister is interested in Vifor due to its various iron deficiency and iron deficiency anaemia therapies
  • CSL shares last traded at $297.27 each on Monday

CSL (CSL) is gearing up to raise capital for the first time in over five years.

The additional funds will help the ASX-10 lister fund an acquisition, as takeover talks with Vifor Pharma continue.

The healthcare giant publicly confirmed it was holding talks about a transaction with Vifor on Monday.

Specifically, CSL is believed to be interested in buying the Swiss-based pharmaceutical company.

The ASX-listed biotechnology business entered a trading halt on Tuesday and is due to remain halted from trade until Thursday.

A full announcement on the capital raise and acquisition is expected to be released on that date unless an announcement can be made sooner.

CSL is interested in a deal with Vifor due to its various iron deficiency and iron deficiency anaemia therapies.

The treatments complement CSL’s own suite of therapies for serious blood diseases, as well as vaccinations — including the AstraZeneca COVID-19 vaccine.

Before today’s trading halt, shares in CSL last traded at $297.27 each on Monday.

CSL by the numbers
More From The Market Herald

" Redflow (ASX:RFX) plans capital raise

Battery makers Redflow (ASX:RFX) enters into a trading halt as it plans for an upcoming capital…

" Strategic Energy Resources (ASX:SER) to raise $500k

Strategic Energy Resources (ASX:SER) enters a trading halt ahead of a $500,000 placement.
Opthea (ASX:OPT) - CEO and MD, Megan Baldwin

" Opthea (ASX:OPT) enters trading halt amid capital raise and funding agreement

Opthea (ASX:OPT) has entered into a trading halt ahead of a capital raise.